These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37028917)

  • 21. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
    Bedikian AY; Legha SS; Mavligit G; Carrasco CH; Khorana S; Plager C; Papadopoulos N; Benjamin RS
    Cancer; 1995 Nov; 76(9):1665-70. PubMed ID: 8635073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing.
    Kalirai H; Dodson A; Faqir S; Damato BE; Coupland SE
    Br J Cancer; 2014 Sep; 111(7):1373-80. PubMed ID: 25058347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors of liver metastases from uveal melanoma.
    Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prognostic classification system for uveal melanoma based on a combination of patient age and sex, the American Joint Committee on Cancer and the Cancer Genome Atlas models.
    Gill VT; Sabazade S; Herrspiegel C; Ewens KG; Opalko A; Dan N; Christersdottir T; Berg Rendahl A; Shields CL; Seregard S; Ganguly A; Stålhammar G
    Acta Ophthalmol; 2023 Feb; 101(1):34-48. PubMed ID: 35801361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic disease in uveal melanoma: importance of a genetic profile?
    Van Beek JG; Koopmans AE; Vaarwater J; Verdijk RM; de Klein A; Naus NC; Kiliç E
    Melanoma Res; 2015 Oct; 25(5):447-9. PubMed ID: 26086698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations.
    Durante MA; Walter SD; Paez-Escamilla M; Tokarev J; Decatur CL; Dubovy SR; Schefler AC; Harbour JW
    JAMA Ophthalmol; 2019 Dec; 137(12):1434-1439. PubMed ID: 31580399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma.
    Livingstone E; Zaremba A; Horn S; Ugurel S; Casalini B; Schlaak M; Hassel JC; Herbst R; Utikal JS; Weide B; Gutzmer R; Meier F; Koelsche C; Hadaschik E; Sucker A; Reis H; Merkelbach-Bruse S; Siewert M; Sahm F; von Deimling A; Cosgarea I; Zimmer L; Schadendorf D; Schilling B; Griewank KG
    Br J Dermatol; 2020 Nov; 183(5):928-939. PubMed ID: 32064597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uveal tumour resection.
    Char DH; Miller T; Crawford JB
    Br J Ophthalmol; 2001 Oct; 85(10):1213-9. PubMed ID: 11567967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of HSP-27, BAP1, BRAF V600E, CCR7, and PD-L1 expression in uveal melanoma on enucleated eyes and metastatic liver tumors.
    Ağın A; Kiratli H; Guresci S; Babaoglu B; Karakaya J; Soylemezoglu F
    Int J Biol Markers; 2022 Jun; 37(2):200-209. PubMed ID: 35341390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
    Wang XY; Wang Z; Huang JB; Ren XD; Ye D; Zhu WW; Qin LX
    Tumour Biol; 2017 Jun; 39(6):1010428317699111. PubMed ID: 28618948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival.
    Smith SL; Damato BE; Scholes AG; Nunn J; Field JK; Heighway J
    Br J Cancer; 2002 Nov; 87(11):1308-13. PubMed ID: 12439722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in uveal melanoma.
    Singh AD; Shields CL; Shields JA
    Melanoma Res; 2001 Jun; 11(3):255-63. PubMed ID: 11468514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
    Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
    PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma.
    Damato B; Coupland SE
    Eye (Lond); 2009 Dec; 23(12):2152-60; quiz 2161-2. PubMed ID: 19876071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma.
    Nell RJ; Menger NV; Versluis M; Luyten GPM; Verdijk RM; Madigan MC; Jager MJ; van der Velden PA
    BMC Cancer; 2021 Feb; 21(1):164. PubMed ID: 33588787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA class II antigen expression in uveal melanoma: correlation with clinicopathological features.
    Krishnakumar S; Abhyankar D; Lakshmi SA; Shanmugam MP; Pushparaj V; Biswas J
    Exp Eye Res; 2003 Aug; 77(2):175-80. PubMed ID: 12873447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.